The disorder that hides in ordinary, everyday tiredness
Source Entity
Latest News: Todays Latest News Headlines from India & World | Hindustan Times | Hindustan Times
Sleep apnoea remains critically underdiagnosed in India, often dismissed as routine exhaustion or aging. New pharmacological advancements are now emerging to complement traditional treatments like CPAP masks.
The Hidden Epidemic of Sleep Apnoea
In many Indian households, the rhythmic sound of snoring is often dismissed as a benign byproduct of aging or a long day's work. However, sleep physicians in Delhi warn that this normalization masks a dangerous, chronic condition: obstructive sleep apnoea (OSA). Patients frequently delay professional consultation for three to six years after the onset of symptoms, often only seeking help when a partner observes alarming pauses in breathing. This delay underscores a significant public health challenge where the line between 'tiredness' and a medical disorder is dangerously blurred.
The Failure of Conventional Coping Mechanisms
Before seeking clinical intervention, many individuals attempt to self-manage their fatigue through lifestyle adjustments. Dr. Akshay Budhraja of Aakash Healthcare notes that patients often cycle through mattress replacements, caffeine reduction, and sleep hygiene modifications, ignoring the underlying physiological obstruction. This trial-and-error approach delays diagnosis and allows the cardiovascular and metabolic toll of oxygen deprivation to accumulate silently, complicating the health profile of the patient by the time they finally enter a clinic.
Beyond the 'Overweight' Stereotype
The perception that sleep apnoea exclusively affects individuals with higher body mass indices is a diagnostic trap. Expert estimates suggest that 25% to 30% of apnoea patients are not overweight, leading to missed diagnoses in thinner individuals. This misconception often results in physicians overlooking sleep studies for patients who do not fit the traditional physical profile, leaving a significant segment of the population at risk for untreated sleep-disordered breathing.
Comorbidities and the Mask Era
For many, the discovery of apnoea happens incidentally during the treatment of other chronic conditions. Patients often present with hypertension that remains resistant to medication or diabetes that refuses to stabilize, only to find that sleep apnoea is the primary driver of their systemic instability. Since the introduction of the CPAP mask forty years ago, it has remained the gold standard for treatment, but its reliance on physical hardware can be a barrier to patient compliance.
A New Frontier in Pharmacology
After decades of relying primarily on positive airway pressure devices, the medical community is seeing a shift. Three new drugs are now being developed to target the specific physiological reasons the airway closes during sleep. This represents a significant evolution in sleep medicine, moving away from a one-size-fits-all mechanical solution toward targeted pharmacological therapy that addresses the root cause of airway collapse.
Future Trends and Conclusion
The future of sleep medicine in India lies in bridging the gap between awareness and diagnostic accessibility. As pharmacological treatments move into the mainstream, the stigma and physical discomfort associated with early-era masks may diminish, encouraging more people to seek testing. Addressing sleep apnoea is not merely about curing snoring; it is a critical intervention for managing heart health, metabolic stability, and overall long-term wellness.
Verification Required?